Cox-2 promotes chromogranin A expression and bioactivity: Evidence for a prostaglandin E2-dependent mechanism and the involvement of a proximal cyclic adenosine 5′-monophosphate-responsive element

Endocrinology

Volumn 148, Issue 9, 2007, Pages 4310-4317

  Connolly, Roisin ^a   Gates, Damien ^a   Loh, Nellie ^b   Baban, Dilair ^c   Thakker, Rajesh ^b   Johnston, Brian ^a   McCance, David ^a   Ardill, Joy ^a   O'Connor, Daniel T ^d   Taupenot, Laurent ^d   McGinty, Ann ^a,e  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^e Mulhouse Building ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOGRANIN A; CYCLIC AMP; CYCLOOXYGENASE 2; DOPAMINE; GENE PRODUCT; MARKER; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NEURON SPECIFIC ENOLASE; POLYPEPTIDE; PROSTAGLANDIN E2;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOLOGICAL ACTIVITY; CELL DIFFERENTIATION; CELL LEVEL; CELL LINE; CHROMAFFIN CELL; CONTROLLED STUDY; GENE EXPRESSION; GENE OVEREXPRESSION; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; INFLAMMATION; NEOPLASM; NEUROENDOCRINE DISEASE; NEUROSECRETORY CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN INDUCTION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; UPREGULATION;

ANIMALS; CHROMOGRANIN A; CYCLIC AMP; CYCLOOXYGENASE 2; DINOPROSTONE; GENE EXPRESSION REGULATION, NEOPLASTIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PC12 CELLS; POLYMERASE CHAIN REACTION; RATS; RNA, NEOPLASM; TRANSFECTION;

EID: 34548068844     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-0167     Document Type: Article

References (31)

1. Smith WL, DeWitt DL, Garavito RM 2000 Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem 69:145-182
2. Zha S, Yegnasubramanian V, Nelson WG, Isaacs WB, De Marzo AM 2004 Cyclooxygenases in cancer: progress and perspective. Cancer Lett 215:1-20
3. Salmenkivi K, Haglund C, Ristimaki A, Arola J, Heikkila P 2001 Increased expression of cyclooxygenase-2 in malignant pheochromocytomas. J Clin Endocrinol Metab 86:5615-5619
4. Mizuno S, Kato K, Hashimoto A, Sugitani M, Sheikh A, Komuro S, Jike T, Iwasaki A, Arakawa Y, Nemoto N 2006 Expression of cyclooxygenase-2 in gastrointestinal carcinoid tumors. J Gastroenterol Hepatol 21:1313-1319
5. McGinty A, Chang Y-W, Sorokin A, Bokemeyer D, Dunn MJ 2000 Cyclo-oxygenase-2 expression inhibits trophic withdrawal apoptosis in nerve growth factor-differentiated PC12 cells. J Biol Chem 275:12095-12101
6. Chang Y-W, Jakobi R, McGinty A, Foschi M, Dunn MJ, Sorokin A 2000 Cyclooxygenase 2 promotes cell survival by stimulation of dynein light chain expression and inhibition of neuronal nitric oxide synthase activity. Mol Cell Biol 20:8571-8579
7. Taupenot L, Harper KL, O'Connor DT 2003 The chromogranin- secretogranin family. N Engl J Med 348:1134-1149
8. Mahapatra NR, O'Connor DT, Vaingankar SM, Sinha Hikim AP, Mahata M, Ray S, Staite E, Wu H, Gu Y, Dalton N, Kennedy BP, Zeigler MG, Ross J, Mahata SK 2005 Hypertension from targeted ablation of chromogranin A can be rescued by the human ortholog. J Clin Invest 115:1942-1952
9. ORourke D, Baban D, Demidova M, Mott R, Hodkin J 2006 Genomic clusters, putative pathogen recognition molecules, and antimicrobial genes are induced by infection of C. elegans with M. nematophilium. Genome Res 16:1005-1016
10. CT method. Methods 25:402-408
11. Laemmli UK 1970 Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685
12. Cadden IS, Johnston BT, Connolly R, Gates D, Tsujimoto Y, Eguchi Y, McGinty A 2005 An investigation into the role of Bcl-2 in neuroendocrine differentiation. Biochem Biophys Acta 326:442-448
13. Cunningham RT, Johnston CF, Irvine GB McIrath EM, McNeill A, Buchanan KD 1990 Development of a radioimmunoassay for neurone specific enolase (NSE) and its application in the study of patients receiving intra hepatic arterial streptozotocin and floxuridine. Clin Chim Acta 189:275-286
14. Kim T, Tao-Cheng J, Eiden LE, Loh YP 2001 Chromogranin A, an "on/off" switch controlling dense-core secretory granule biogenesis. Cell 106:499-509
15. Riggin RM, Kissinger PT 1977 Determination of catecholamines in urine by reverse-phase liquid chromatography with electrochemical detection. Anal Chem 49:2108-2111
16. Wu H, Rozansky DJ, Webster NJG, O'Connor DT 1994 Cell type-specific gene expression in the neuroendocrine system. A neuroendocrine-specific regulatory element in the promoter of chromogranin A, a ubiquitous secretory granule core protein. J Clin Invest 94:118-129
17. Wu H, Mahata SK, Mahata M, Webster NJG, Parmer RJ, O'Connor DT 1995 A functional cyclic AMP response element plays a crucial role in neuroendocrine cell type-specific expression of the secretory granule protein chromogranin A. J Clin Invest 96:568-578
18. Taupenot L, Mahata SK, Wu H, O'Connor DT 1998 Peptidergic activation of transcription and secretion in chromaffin cells. Cis and trans signaling determinants of pituitary adenylyl cyclase-activating polypeptide (PACAP). J Clin Invest 101:863-876
19. Greene LA, Tischler AS 1976 Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci USA 73:2424-2428
20. Stivanello M, Berutti A, Torta M, Termine A, Tampellini M, Gorzegno G, Angeli A, Dogliotti L 2001 Circulating chromogranin A in the assessment of patients with neuroendocrine tumours. A single institution experience. Ann Oncol 12(Suppl 2):S73-S77
21. Huh YH, Jeon SH, Yoo SH 2003 Chromogranin B-induced secretory granule biogenesis: comparison with the similar role of chromogranin A. J Biol Chem 278:40581-40589
22. Nakajima T, Hamanaka K, Fukuda T, Oyama T, Kashiwabara K, Sano T 1997 Why is cyclooxygenase-2 expressed in neuroendocrine cells of the human alimentary tract? Pathol Int 47:889-891
23. Tang K, Wu H, Mahata SK, Taupenot L, Rozansky DJ, Parmer RJ, O'Connor DT 1996 Stimulus-transcription coupling in pheochromocytoma cells. Promoter region-specific activation of chromogranin A biosynthesis. J Biol Chem 271:28382-28390
24. Yu DS, Hsieh DS, Chang SY 2003 Modulation of prostate carcinoma cell growth and apoptosis by chromogranin A. J Urol 170:2031-2035
25. Nagasaki O, Fujiuchi Y, Fuse H, Saiki I 2003 Differential effect of chromogranin A fragments on invasion and growth of prostate cancer cells in vitro. Urology 62:553-558
26. Colombo B, Curnis F, Foglieni C, Monno A, Gianluigi A, Corti A 2002 Chromogranin A expression in neoplastic cells affects tumor growth and morphogenesis in mouse models. Cancer Res 62:941-946
27. Stilling GA, Bayliss JM, Jin L, Zhang H, Lloyd RV 2005 Chromogranin A transcription and gene expression in folliculostellate (TtT/GF) cells inhibit cell growth. Endocr Pathol 16:173-186
28. Orr DF, Chen T, Johnsen AH, Chalk R, Buchanan KD, Sloan JM, Rao P, Shaw C 2002 The spectrum of endogenous human chromogranin A-derived peptides identified using a modified proteomin strategy. Proteomics 2:1586-1600
29. Lenders JWM, Eisenhofer G, Mannelli M, Pacak K 2005 Phaeochromocytoma. Lancet 366:665-675
30. Grosser T, Fries S, Fitzgerald GA 2006 Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities. J Clin Invest 116:4-15
31. Cadden IS, Atkinson AB, Johnston B, Pogue K, Connolly R, McCance D, Ardill JES, Russell CF, McGinty A, Cyclooxygenase-2 expression correlates with phaeochromocytoma malignancy. Evidence for a Bcl-2-dependent mechanism. Histopathology, in press